Related People
Litigation & Dispute Resolution partner Chris Kelly (Palo Alto) is quoted on the FTC’s new plans to broaden the types of exclusive pharmaceutical patent rights licenses that require antitrust approval.
Downloads –
Related Capabilities
News
-
February 132023
-
January 182023
Stay up-to-date on our perspectives
Subscribe to Email